TCL Archive In Brief: UICC Honors Center Director’s Efforts To Improve Cancer Control In India March 13, 1998
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010